logo
Global Industrial Company to Report First Quarter 2025 Results on April 29, 2025

Global Industrial Company to Report First Quarter 2025 Results on April 29, 2025

Yahoo22-04-2025
PORT WASHINGTON, NY / / April 22, 2025 / Global Industrial Company (NYSE:GIC), a value-added national distributor of industrial equipment and supplies, today announced that it will release financial results for the first quarter ended March 31, 2025, on Tuesday, April 29, 2025, after U.S. market hours.
Management will host a conference call and question and answer session on the Company's results at 5:00 p.m. Eastern Time on April 29th. To access the call, please dial (412)-317-6347 five minutes prior to the start time. The call will also be available via webcast on the Company's website at https://investors.globalindustrial.com. If you are unable to listen to the call at its scheduled time, the webcast will be archived for approximately 90 days.
About Global Industrial CompanyGlobal Industrial Company (NYSE:GIC), through its operating subsidiaries, is a value-added distributor. Leveraging over 75 years of experience, Global Industrial specializes in providing industrial equipment and supplies to small- to medium-sized businesses, large enterprises, and the public sector. Global Industrial is committed to its customer-centric strategy and leverages a team of subject matter experts, products from its Global Industrial Exclusive BrandsTM, and national vendor relationships to help customers succeed. At Global Industrial, "We Can Supply That®".
Investor/Media Contact:Mike Smargiassi/Collin DreizenThe Plunkett Group212-739-6729mike@theplunkettgroup.com / collin@theplunkettgroup.com
SOURCE: Global Industrial Company
View the original press release on ACCESS Newswire
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SM Energy (SM) Gets a Hold from Wells Fargo
SM Energy (SM) Gets a Hold from Wells Fargo

Business Insider

timean hour ago

  • Business Insider

SM Energy (SM) Gets a Hold from Wells Fargo

Wells Fargo analyst Hanwen Chang maintained a Hold rating on SM Energy on July 18 and set a price target of $30.00. The company's shares closed last Friday at $25.89. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Chang covers the Energy sector, focusing on stocks such as Vital Energy, Matador Resources, and SM Energy. According to TipRanks, Chang has an average return of -2.8% and a 38.24% success rate on recommended stocks. In addition to Wells Fargo, SM Energy also received a Hold from J.P. Morgan's Zach Parham in a report issued on July 10. However, on July 16, Siebert Williams Shank & Co maintained a Buy rating on SM Energy (NYSE: SM). Based on SM Energy's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $844.54 million and a net profit of $182.27 million. In comparison, last year the company earned a revenue of $559.87 million and had a net profit of $131.2 million Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is neutral on the stock. Last month, Richard A. Jenkins, the SVP – Utah of SM sold 7,726.00 shares for a total of $220,113.74.

Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT

Yahoo

timean hour ago

  • Yahoo

Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT

AbbVie Inc. (NYSE:ABBV) is one of the best long term low volatility stocks to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a Buy rating on AbbVie Inc. (NYSE:ABBV) and set a price target of $250.00. A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist. AbbVie Inc. (NYSE:ABBV) reported positive fiscal Q1 2025 results that support the optimistic outlook, with adjusted diluted EPS reaching $2.46, experiencing a 6.5% growth. The company also reported $13.343 billion in net revenue for the first quarter of 2025, reflecting an 8.4% growth on a reported basis or 9.8% on an operational basis. AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions. While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi

Yahoo

timean hour ago

  • Yahoo

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy now. On July 16, Thermo Fisher Scientific Inc. (NYSE:TMO) announced plans to strategically expand its partnership with Sanofi to support additional drug product manufacturing in the United States. A workstation in a research lab stocked with laboratory products and services. As part of the partnership, Thermo Fisher Scientific Inc. (NYSE:TMO) would acquire Sanofi's manufacturing site in Ridgefield, New Jersey, and would continue to produce and develop a portfolio of therapies for Sanofi. Thermo Fisher Scientific Inc. (NYSE:TMO) also plans to expand use of the site to satisfy the rising demand from biotech and pharma customers for US manufacturing capacity. The Ridgefield site will join Thermo Fisher Scientific Inc. (NYSE:TMO) after the completion of the transaction, and comprises a state-of-the-art sterile fill-finish and packaging facility with over 200 employees. Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments. While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store